U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833514) titled 'Misocholic Tablets for Non-Viral Elevated Liver Enzymes' on Sept. 16.
Brief Summary: Elevated liver enzymes are common laboratory abnormalities that may result from alcohol-related liver disease, drug-induced liver injury, or non-alcoholic fatty liver disease (NAFLD). Persistent elevation of liver enzymes may indicate ongoing hepatocellular injury and increase the risk of progressive liver disease. Current management primarily focuses on treating the underlying cause and providing supportive care, while evidence for effective hepatoprotective therapies remains limited.
This randomized, double-blind, placebo-controlled clinical tri...